Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.945 USD | -1.56% | -11.68% | -10.00% |
04-01 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-26 | Transcript : Quince Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-10.00% | 41.49M | |
+19.74% | 46.81B | |
-0.70% | 41.37B | |
+47.07% | 41.29B | |
-6.20% | 28.87B | |
+11.73% | 26.06B | |
-19.69% | 19.13B | |
+32.74% | 12.39B | |
+0.40% | 12.08B | |
+0.45% | 11.96B |
- Stock Market
- Equities
- QNCX Stock
- News Quince Therapeutics, Inc.
- Canaccord Genuity Downgrades Cortexyme to Hold From Buy